ENTITY
Eubiologics

Eubiologics (206650 KS)

28
Analysis
Health CareSouth Korea
Eubiologics Co. Ltd. researches and develops biopharmaceuticals. The Company offers bacterial vaccines for new epidemics and antibiotic resistance. Eubiologics operates in South Korea.
more
Refresh
bullishEubiologics
22 Feb 2023 18:51

EuBiologics (206650 KS): Accelerated Double-Digit Sales Growth In 2022; Strong Demand to Continue

Eubiologics reported 41% sales growth in 2022, driven by increased supply of cholera vaccine to UNICEF. Cholera outbreak continues this year,...

Logo
298 Views
Share
bullishLi Auto
08 Jan 2023 05:45

Index Rebalance & ETF Flow Recap: HSCEI, HSTECH, HSI, HSCI, KS200, KQ150, CSI300, SENSEX, LQ45, PSEi

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
683 Views
Share
bullishSun Kwang
02 Jan 2023 05:55

KOSDAQ150 Index Rebalance Preview (June): Changes Keep Rolling In

Early in the review period, we see 9 potential changes for the KOSDAQ150 in June. The potential adds have outperformed the potential deletes by a...

Logo
571 Views
Share
bullishEubiologics
18 Mar 2022 17:09

EuBiologics (206650 KS): Base Business Recovery; COVID Vaccine Undergoing Phase 3 Trial

EuBiologics has bagged contract to supply 67.1 million doses of oral cholera vaccine to UNICEF. Its COVID-19 vaccine candidate is undergoing phase...

Logo
372 Views
Share
bullishM2N Co.,Ltd
02 Nov 2021 13:43

KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover

At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...

Logo
575 Views
Share
x